Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 301–400 of 1,022
Cardiovascular Risk Factors for Alzheimer's Disease
Rosendorff, C., Beeri, M. S., & Silverman, J. M. (2007) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2007.06696.x · Cited by 151
Homocysteine: a biomarker in neurodegenerative diseases
Herrmann, W., & Obeid, R. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.084 · Cited by 169
Randomized Multicenter Investigation of Folate Plus Vitamin B 12 Supplementation in Schizophrenia
Roffman, J. L., Lamberti, J. S., Achtyes, E. D., Macklin, E. A., Galendez, G. C., Raeke, L. H., Silverstein, N. J., Smoller, J. W., Hill, M. B., & GOFF, D. C. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.900 · Cited by 171
Zhang, C., Wei, W., Liu, Y., Peng, J.-H., Tian, Q., Liu, G., Zhang, Y., & Wang, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081036 · Cited by 164
Plasma Homocysteine Levels and Risk of Alzheimer Disease
Bissell, M. G. (2006) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)70193-2 · Cited by 151
Histone methyltransferases, diet nutrients and tumour suppressors
Huang, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc819 · Cited by 170
Vascular Dementia Prevention: A Risk Factor Analysis
Román, G. C. (2005) · Cerebrovascular Diseases · doi:10.1159/000089361 · Cited by 150
Elevated Homocysteine Levels in Young Male Patients With Schizophrenia
Levine, J., Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1790 · Cited by 147
Brewer, G. J. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719777 · Cited by 149
“As homocysteine levels in blood increases, the risk of AD increases [8], as well as the risk for atherosclerotic disease.”
BackgroundMcCully, K. S. (2009) · PubMed · Cited by 178
Homocysteine and Redox Signaling
Zou, C.-G., & Banerjee, R. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.547 · Cited by 147
“neurodegenerative conditions, including Alzheimer’s disease (9, 76), stroke (27), and Parkinson’s disease (5).”
Methionine transmethylation and transsulfuration in the piglet gastrointestinal tract
Riedijk, M. A., Stoll, B., Chacko, S., Schierbeek, H., Sunehag, A. L., van Goudoever, J. B., & Burrin, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607965104 · Cited by 148
Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease
Irizarry, M. C., Gurol, M. E., Raju, S., Diaz-Arrastia, R., Locascio, J. J., Tennis, M., Hyman, B. T., Growdon, J. H., Greenberg, S. M., & Bottiglieri, T. (2005) · Neurology · doi:10.1212/01.wnl.0000183063.99107.5c · Cited by 147
Sarter, M. F., & Bruno, J. P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.011 · Cited by 160
“The recent finding that increased plasma homocysteine levels are a profound risk factor for dementia and AD corresponds with these hypotheses [42,184].”
BackgroundO'Suilleabhain, P. E., Sung, V., Hernandez, C., Lacritz, L., Dewey Jr, R. B., Bottiglieri, T., & Diaz-Arrastia, R. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.865 · Cited by 148
“This cutoff was used as the longtime standard in our laboratory, and this is the cutoff used in an influential prior study.(6) Analysis of covariance was used (GLM procedure; SAS Institute Inc, Cary, NC), controlling for daily levodopa dose, age, sex, and duration of PD.”
MethodAbraham, H. M. A., Wolfson, L., Moscufo, N., Guttmann, C. R. G., Kaplan, R. F., & White, W. B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.121 · Cited by 146
“Homocysteine, an important inflammatory marker associated with atherosclerosis and large artery vascular disease, has also been found to be strongly associated with the development of dementia, including Alzheimer’s disease, in a sample from the Framingham study.(40) In addition, an analysis of 259 stroke-free partici…”
Wang, Z., Zhu, W., Xing, Y., Jia, J., & Tang, Y. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab057 · Cited by 144
Redox Homeostasis and Cellular Stress Response in Aging and Neurodegeneration
Calabrese, V., Cornelius, C., Mancuso, C., Lentile, R., Stella, A. M. G., & Butterfield, D. A. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60327-029-8_17 · Cited by 144
Folate biofortification in food plants
Bekaert, S., Storozhenko, S., Mehrshahi, P., Bennett, M. J., Lambert, W. E., Gregory, J. F., Schubert, K. R., Hugenholtz, J., Straeten, D. V. D., & Hanson, A. D. (2007) · Trends in Plant Science · doi:10.1016/j.tplants.2007.11.001 · Cited by 150
Pu, F., Huang, Z., Ren, J., & Qu, X. (2010) · Analytical Chemistry · doi:10.1021/ac101647k · Cited by 146
Steele, M. L., Fuller, S. L., Patel, M., Kersaitis, C., Ooi, L., & Münch, G. W. (2013) · Redox Biology · doi:10.1016/j.redox.2013.08.006 · Cited by 162
van Rossum, I. A., Vos, S., Handels, R., & Visser, P. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091606 · Cited by 145
S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system
Tehlivets, O., Malanović, N., Visram, M., Pavkov‐Keller, T., & Keller, W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.007 · Cited by 151
Lifestyle-related factors in predementia and dementia syndromes
Solfrizzi, V., Capurso, C., D’Introno, A., Colacicco, A. M., Santamato, A., Ranieri, M., Fiore, P., Capurso, A., & Panza, F. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.133 · Cited by 144
Autoantibodies Against N -Homocysteinylated Proteins in Humans: Implications for Atherosclerosis
Undas, A., Perła‐Kaján, J., Łaciński, M., Trzeciak, W. H., Kaźmierski, R., & Jakubowski, H. (2004) · Stroke · doi:10.1161/01.str.0000128412.59768.6e · Cited by 156
Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort
Ganguli, M., Fu, B., Snitz, B. E., Hughes, T. F., & Chang, C.-C. H. (2013) · Neurology · doi:10.1212/wnl.0b013e318295d776 · Cited by 144
Betaine attenuates Alzheimer‐like pathological changes and memory deficits induced by homocysteine
Chai, G., Jiang, X., Ni, Z., Ma, Z., Xie, A., Cheng, X., Wang, Q., Wang, J., & Liu, G. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12094 · Cited by 143
“Epidemiology and accumulating clinical investigations have shown that the elevated plasma homocysteine (Hcy) has a positive correlation with the occurrence of AD, and thus hyperhomocysteinemia (Hhcy) has been proposed to be a strong and independent risk factor of AD (Clarke et al. 1998; McCaddon et al. 1998; Seshadri…”
BackgroundEndogenous Allosteric Modulators of G Protein–Coupled Receptors
van der Westhuizen, E. T., Valant, C., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221606 · Cited by 165
“…increased plasma levels of homocysteine are strong indicators of neurologic disorders and could therefore play a detrimental role in various diseases, including dementia, Alzheimer’s, Huntington’s, and Parkinson’s diseases (Seshadri et al., 2002; Morris, 2003; Andrich et al., 2004; Müller, 2008).”
BackgroundHu, Q., Yu, C., Xia, X., Zeng, F., & Wu, S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.03.011 · Cited by 143
“…and liver damage (Shahrokhian, 2001; Weerapana et al., 2010); elevated Hcy might cause Alzheimer's and cardiovascular diseases (Refsum et al., 1998; Seshadri et al., 2002); and abnormal GSH level is involved with liver damage, leucocyte loss, psoriasis and cancers (Townsend et al., 2003; Estrela…”
BackgroundThe Influence of Micronutrients on Cognitive Function and Performance
Huskisson, E., Maggini, S., & Ruf, M. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500101 · Cited by 144
Yang, Q.-H., Botto, L. D., Gallagher, M. L., Friedman, J. M., Sanders, C., Koontz, D. A., Nikolova, S., Erickson, J. D., & STEINBERG, K. K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.1.232 · Cited by 160
Poor Oral Health as a Chronic, Potentially Modifiable Dementia Risk Factor: Review of the Literature
Noble, J. M., Scarmeas, N., & Papapanou, P. N. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0384-x · Cited by 142
“For example, vascular risk factors [27, 28], including diabetes mellitus [28–33], dyslipidemia [34], hypertension [35], atrial fibrillation [36], smoking [28, 37–39], hyperhomocysteinemia [40], and obesity [41–45], have been associated with the development of dementia, including AD.”
BackgroundSerum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in Japanese
Iso, H., Moriyama, Y., Sato, S., Kitamura, A., Tanigawa, T., Yamagishi, K., Imano, H., Ohira, T., Okamura, T., Naito, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131942.77635.2d · Cited by 143
Homocysteine Induces Inflammation in Retina and Brain
Elsherbiny, N. M., Sharma, I., Kira, D., Alhusban, S., Samra, Y. A., Jadeja, R. N., Martin, P. M., Al‐Shabrawey, M., & Tawfik, A. M. (2020) · Biomolecules · doi:10.3390/biom10030393 · Cited by 151
“HHcy in the elderly population (≥60 years) resulted in doubling the risk of AD compared to those with lower blood Hcy level [69].”
BackgroundHo, Y.-S., Yu, M.-S., Yang, X.-F., So, K.-F., Yuen, W.-H., & Chang, R. C.-C. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1280 · Cited by 142
“A 5 μmol/liter increment of plasma Hcy level increases the risk of AD by 40% [8].”
BackgroundMethylation demand: a key determinant of homocysteine metabolism.
Brosnan, J. T., Jacobs, R. L., Stead, L. M., & Brosnan, M. E. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3580 · Cited by 142
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
Doraiswamy, P. M. (2002) · CNS Drugs · doi:10.2165/00023210-200216120-00003 · Cited by 150
Emerging roles for folate and related B-vitamins in brain health across the lifecycle
McGarel, C., Pentieva, K., Strain, J. J., & McNulty, H. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001554 · Cited by 141
Folates and Folic Acid: From Fundamental Research Toward Sustainable Health
Blancquaert, D., Storozhenko, S., Loizeau, K., Steur, H. D., Brouwer, V. D., Viaene, J., Ravanel, S., Rébeillé, F., Lambert, W. E., & Straeten, D. V. D. (2010) · Critical Reviews in Plant Sciences · doi:10.1080/07352680903436283 · Cited by 165
“Low folate status is also associated with the occurrence of several neurodegenerative disorders, including Alzheimer’s disease (Seshadri et al., 2002), a higher risk of cardio vascular disease (Stanger, 2004) and development of a range of cancers (Choi and Friso, 2005); however, no causal relationship has been establi…”
BackgroundInfluentialChen, H., Tang, Y., & Lin, W. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.11.014 · Cited by 140
Jensen, G. L. (2006) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607106030005453 · Cited by 141
Alzheimer's disease and diet: a systematic review
Yusufov, M., Weyandt, L. L., & Piryatinsky, I. (2017) · International Journal of Neuroscience · doi:10.3109/00207454.2016.1155572 · Cited by 140
Ataie, A., Sabetkasaei, M., Haghparast, A., Moghaddam, A. H., & Kazeminejad, B. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.06.009 · Cited by 143
“An elevated plasma level of Hcy (more than 14 μM) is termed Hyperhomocysteinemia (HHCY) (Seshadri et al., 2002).”
BackgroundJiang, X., Huang, J., Song, D., Deng, R., Wei, J., & Zhang, Z. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00018 · Cited by 139
Kennedy, B. P., Bottiglieri, T., Arning, E., Ziegler, M. G., Hansen, L. A., & Masliah, E. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0096-5 · Cited by 139
“Elevations of plasma homocysteine have been repeatedly found in Alzheimer’s disease (Clarke et al., 1998; McCaddon et al., 1998; Miller et al., 1997; Seshadri et al., 2002; Postiglione et al., 2001; Joosten et al., 1997).”
BackgroundCross-talk between Cys34 and Lysine Residues in Human Serum Albumin Revealed by N-Homocysteinylation
Głowacki, R., & Jakubowski, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313268200 · Cited by 144
Wang, F., Guo, Z., Li, X., Li, X., & Zhao, C. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201403450 · Cited by 138
A highly sensitive near-infrared fluorescent probe for cysteine and homocysteine in living cells
Kong, F., Liu, R., Chu, R., Wang, X., Xu, K., & Tang, B. (2013) · Chemical Communications · doi:10.1039/c3cc45519j · Cited by 144
Liu, J., & Ames, B. N. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047161 · Cited by 137
“Hyperhomocysteinemia has also been shown in a clinical study as an independent risk factor for development of dementia and AD (Seshadri et al. 2002).”
BackgroundHomocysteine-Mediated Reactivity and Assembly of Gold Nanoparticles
Lim, I.-I. S., Ip, W., Crew, E., Njoki, P. N., Mott, D. M., Zhong, C., Pan, Y., & Zhou, S. (2006) · Langmuir · doi:10.1021/la062334t · Cited by 147
Colorimetric Detection of Thiols Using a Chromene Molecule
Huo, F., Sun, Y., Su, J., Chao, J., Zhi, H., & Yin, C. (2009) · Organic Letters · doi:10.1021/ol901951h · Cited by 137
The Role of B Vitamins in Preventing and Treating Cognitive Impairment and Decline
Morris, M. S. (2012) · Advances in Nutrition · doi:10.3945/an.112.002535 · Cited by 165
“(43) reported that they could find an association between Hcy and MMSE score decrease only after $4 y of followup from the baseline examination for their analyses.”
BackgroundGene–Diet Interactions in Brain Aging and Neurodegenerative Disorders
Mattson, M. P. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_2-200309021-00012 · Cited by 136
“Many patients with Alzheimer disease and Parkinson disease have elevated homocysteine levels; a recent prospective study of the Framingham Heart Study cohort revealed that persons with elevated homocysteine levels are at increased risk for Alzheimer disease (16).”
BackgroundCassidy, K., Kotynia-English, R., Acres, J., Flicker, L., Lautenschlager, N. T., Almeida, O. P., Cassidy, K., Kotynia-English, R., Acres, J., Flicker, L., et al. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01485.x · Cited by 137
“More recently high plasma homocysteine has been linked to dementia in both case-control studies [54] and cohort studies [55].”
BackgroundMechanisms of Alcohol-Induced Endoplasmic Reticulum Stress and Organ Injuries
Ji, C. (2011) · Biochemistry Research International · doi:10.1155/2012/216450 · Cited by 143
Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important
Elias, M. F., Sullivan, L. M., D'Agostino, R. B., Elias, P. K., Jacques, P. F., Selhub, J., Seshadri, S., Au, R., Beiser, A., & Wolf, P. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi259 · Cited by 136
“The screening and examination procedures for dementia have been described previously (5).”
MethodSelf-citationDementia associated with alcohol and other drug use
Hulse, G. K., Lautenschlager, N. T., Tait, R. J., & Almeida, O. P. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205001985 · Cited by 135
Hypothesis: Hyperhomocysteinemia is an indicator of oxidant stress
Hoffman, M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.09.009 · Cited by 145
“Mounting evidence suggests that high homocysteine levels are also a predictor of osteoporotic fractures [6] and are associated with impaired cognitive function and Alzheimer’s disease [7,8].”
BackgroundChakrabarti, S., Kumar Khemka, V., Banerjee, A., Chatterjee, G., Ganguly, A., & Biswas, A. (2015) · Aging and disease · doi:10.14336/ad.2014.002 · Cited by 134
“Many epidemiological studies have simultaneously measured plasma total homocysteine, folate, vitamin B12, vitamin B6 in cohorts in relation to AD risk and established that hyperhomocysteinemia is associated with deficiency of these vitamins [118, 122, 123, 124, 125].”
BackgroundHomocysteine and cognitive function in the Sacramento Area Latino Study on Aging
Miller, J. W., Green, R., Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., & Haan, M. N. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.441 · Cited by 134
“Sheshadri et al (10) showed that incident dementia over an 8-y period was higher in individuals with the highest baseline concentrations of homocysteine.”
BackgroundResultZiemińska, E., Stafiej, A., & Łazarewicz, J. W. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00038-x · Cited by 145
The Future of Precision Medicine in the Cure of Alzheimer’s Disease
Arafah, A., Khatoon, S., Rasool, I., Khan, A., Rather, M. A., Abujabal, K. A., Faqih, Y. A. H., Rashid, H., Rashid, S. M., Bilal Ahmad, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020335 · Cited by 133
“Homocysteine contributes to inflammation, and it has been linked to memory loss and a higher risk of AD [75,76].”
BackgroundBerry Fruit Enhances Beneficial Signaling in the Brain
Miller, M. G., & Shukitt‐Hale, B. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2036033 · Cited by 153
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
Hagerman, R. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1794 · Cited by 131
“Hyperhomocys-teinemia is an independent risk factor for vascular disease, including cerebrovascular disease (Refsum et al 1998), and is associated with both an increased prevalence and incidence of AD and dementia (Clarke et al 1998; Miller et al 2002; Seshadri et al 2002; Haan et al 2007).”
Kwon, N., Hu, Y., & Yoon, J. (2018) · ACS Omega · doi:10.1021/acsomega.8b01717 · Cited by 135
Hainsworth, A. H., Yeo, N., Weekman, E. M., & Wilcock, D. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.015 · Cited by 151
Folates in plants: biosynthesis, distribution, and enhancement
Rébeillé, F., Ravanel, S., Jabrin, S., Douce, R., Storozhenko, S., & Straeten, D. V. D. (2006) · Physiologia Plantarum · doi:10.1111/j.1399-3054.2006.00587.x · Cited by 132
“Increased plasmaHcy content may also be a risk factor for different forms of dementia including Alzheimer’s disease (Seshadri et al. 2002).”
BackgroundLevine, J., Stahl, Z., Sela, B., Ruderman, V., Shumaico, O., Babushkin, I., Osher, Y., Bersudsky, Y., & Belmaker, R. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.009 · Cited by 132
Vegetarian lifestyle and monitoring of vitamin B-12 status
Herrmann, W., & Geisel, J. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00307-8 · Cited by 127
Folic acid handling by the human gut: implications for food fortification and supplementation
Patanwala, I., King, M. J., Barrett, D. A., ROSE, J. W., Jackson, R., Hudson, M., Philo, M. R., Dainty, J. R., Wright, A. J., Finglas, P. M., et al. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.080507 · Cited by 132
Homocysteine and cognitive function in healthy elderly community dwellers in Italy
Ravaglia, G., Forti, P., Maioli, F., Muscari, A., Sacchetti, L., Arnone, G., Nativio, V., Talerico, T., & Mariani, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.668 · Cited by 131
Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance
Lehotský, J., Tóthová, B., Kovalská, M., Dobrota, D., Beňová, A., Kalenská, D., & Kaplán, P. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00538 · Cited by 139
Luchsinger, J. A., Noble, J. M., & Scarmeas, N. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0057-8 · Cited by 160
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Prohovnik, I., Perl, D. P., Davis, K. L., Libow, L., Lesser, G., & Haroutunian, V. (2006) · Neurology · doi:10.1212/01.wnl.0000191298.68045.50 · Cited by 130
Jiang, W., Cao, Y., Liu, Y., & Wang, W. (2010) · Chemical Communications · doi:10.1039/b926070f · Cited by 130
Ma, F., Wu, T., Zhao, J., Ji, L., Song, A., Zhang, M., & Huang, G. (2017) · Nutrients · doi:10.3390/nu9070725 · Cited by 142
Homocysteine and cognitive function in elderly people
Garcia, A. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031586 · Cited by 130
Homocysteine,MTHFR gene polymorphisms, and cardio-cerebrovascular risk
Trabetti, E. (2008) · Journal of Applied Genetics · doi:10.1007/bf03195624 · Cited by 145
Li, J., Chu, J., Barrero, C., Merali, S., & Praticò, D. (2014) · Annals of Neurology · doi:10.1002/ana.24145 · Cited by 129
“Numerous studies have reported the association between high circulating levels of Hcy and AD, and longitudinal observations have found that the effect of Hcy on AD is independent of other confounders.(3,21,22) However, conflicting results have also been reported.”
BackgroundResultFord, A. H., & Almeida, O. P. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111739 · Cited by 130
“Observational studies have shown that high tHcy increases the risk of cognitive impairment with or without dementia [4–6], but the nature of this research makes it difficult to determine if these associations are truly causal.”
Primary Cerebral Blood Flow Deficiency and Alzheimer's Disease: Shadows and Lights
Mazza, M., Marano, G., Traversi, G., Bria, P., & Mazza, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090700 · Cited by 129
Kumar, K. S. S., Girish, Y. R., Ashrafizadeh, M., Mirzaei, S., Rakesh, K. P., Gholami, M. H., Zabolian, A., Hushmandi, K., Orive, G., Kadumudi, F. B., et al. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214135 · Cited by 131
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Beeri, M. S., Rapp, M., Silverman, J. M., Schmeidler, J., Grossman, H. T., Fallon, J. T., Purohit, D. P., Perl, D. P., Siddiqui, A., Lesser, G., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000210447.19748.0b · Cited by 129
Burton, E. J., McKeith, I. G., Burn, D. J., Firbank, M., & O'Brien, J. T. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000236596.56982.1c · Cited by 135
Vafai, S. B., & Stock, J. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02702-3 · Cited by 129
Lewerin, C., Matousek, M., Steen, G., Johansson, B. E. A., Steen, B. C., & Nilsson‐Ehle, H. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1155 · Cited by 141
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study
Hooshmand, B., Polvikoski, T. M., Kivipelto, M., Tanskanen, M., Myllykangas, L., Erkinjuntti, T., Mäkelä, M., Oinas, M., Paetau, A. E., Scheltens, P., et al. (2013) · Brain · doi:10.1093/brain/awt206 · Cited by 135
“…between homocysteine and dementia/Alzheimer’s disease, rate of cognitive decline, or structural brain changes have shown conflicting results (Seshadri et al., 2002, 2008; Vermeer et al., 2002; den Heijer et al., 2003; Smith, 2008; Hooshmand et al., 2010, 2012; Rastas et al., 2010;…”
ResultRiboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases
Udhayabanu, T., Manole, A., Rajeshwari, M., Varalakshmi, P., Houlden, H., & Ashokkumar, B. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050052 · Cited by 139
“Elevated plasma levels of homocysteine have been documented due to the impaired activity of methylenetetrahydrofolate reductase (MTHFR) in one carbon metabolism of the homocysteine remethylation pathway, which is a FAD-dependent flavoenzyme [63].”
BackgroundFluorescent chemodosimeter for Cys/Hcy with a large absorption shift and imaging in living cells
Hu, M., Fan, J., Li, H., Song, K., Wang, S., Cheng, G., & Peng, X. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00957a · Cited by 127
Ozawa, M., Ohara, T., Ninomiya, T., Hata, J., Yoshida, D., Mukai, N., Nagata, M., Uchida, K., Shirota, T., Kitazono, T., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12887 · Cited by 127
Barberger-Gateau, P., Samieri, C., Feart, C., & Plourde, M. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391926 · Cited by 126
“Elevated serum homocysteine is a cardiovascular risk factor which is also associated with increased risk of cognitive decline [114-116], dementia [116-118] and AD [117-119].”
BackgroundGao, Q., Zhang, W., Song, B., Zhang, R., Guo, W., & Yuan, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04925 · Cited by 127
Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
Doulberis, M., Kotronis, G., Thomann, R., Polyzos, S. A., Boziki, M., Gialamprinou, D., Deretzi, G., Katsinelos, P., & Kountouras, J. (2018) · Helicobacter · doi:10.1111/hel.12454 · Cited by 127
Implications of plasma thiol redox in disease
Oliveira, P. V. S., & Laurindo, F. R. M. (2018) · Clinical Science · doi:10.1042/cs20180157 · Cited by 127
Brown, A. K., Liu-Ambrose, T., Tate, R., & Lord, S. R. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.049882 · Cited by 127
“with impaired cognitive performance,[42] AD,[43] and cerebral white matter lesions.”
BackgroundPublic Health Significance of Elevated Homocysteine
Selhub, J. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s116 · Cited by 139
Self-citationWu, Z., Li, W., Chen, J., & Yu, C. (2013) · Talanta · doi:10.1016/j.talanta.2013.11.065 · Cited by 126
Chouraki, V., Preis, S. R., Yang, Q., Beiser, A., Li, S., Larson, M. G., Weinstein, G., Wang, T. J., Gerszten, R. E., Vasan, R. S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.009 · Cited by 126
Self-citationBetaine-Homocysteine Methyltransferase
Evans, J. C., Huddler, D. P., Jiráček, J., Castro, C., Millian, N. S., Garrow, T. A., & Ludwig, M. L. (2002) · Structure · doi:10.1016/s0969-2126(02)00796-7 · Cited by 141
Will a Healthy Lifestyle Help Prevent Alzheimer's Disease?
Pope, S. K., Shue, V. M., & Beck, C. (2003) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.24.100901.141015 · Cited by 126
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.